COMPARATIVE PHARMACOECONOMIC EVALUATION OF THE USE OF AFATINIB AND GEFITINIB IN THERAPY FOR LUNG CANCER. (2017). Voprosy Onkologii, 63(1), 38-51. https://doi.org/10.37469/0507-3758-2017-63-1-38-51